Theraclion SA (EPA:ALTHE)
France · Delayed Price · Currency is EUR 0.6600
-0.1100 (-14.29%)
At close: Jan 30, 2026
Theraclion Market Cap
Theraclion has a market cap or net worth of €31.01 million as of January 30, 2026. Its market cap has increased by 168.02% in one year.
Market Cap
31.01M
Enterprise Value
34.42M
Revenue
1.87M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.66
Market Cap Chart
Since April 25, 2014, Theraclion's market cap has decreased from 37.53M to 31.01M, a decrease of -17.38%. That is a compound annual growth rate of -1.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 31.01M | 9.63% |
| Dec 31, 2025 | 28.28M | 85.64% |
| Dec 31, 2024 | 15.24M | -11.33% |
| Dec 29, 2023 | 17.18M | -34.28% |
| Dec 30, 2022 | 26.15M | -12.29% |
| Dec 31, 2021 | 29.81M | -3.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Guerbet | 174.65M |
| Median Technologies | 159.55M |
| Affluent Medical | 75.16M |
| Diagnostic Medical Systems | 35.74M |
| Novacyt | 29.54M |
| Implanet | 29.52M |
| Ikonisys | 25.51M |
| Biosynex | 17.81M |